Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) Inventories, Raw Materials & Components: ¥58.9 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600381 Qinghai Spring Medicinal Resources Technology Co Ltd SHSE:600381
70 GF Score
Price ¥4.29
GF Value ¥5.28
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Qinghai Spring Medicinal Resources Technology Co Inventories, Raw Materials & Components?

Qinghai Spring Medicinal Resources Technology Co SHSE:600381 -1.61% 70 Inventories, Raw Materials & Components is ¥58.9 Mil as of Jun. 2026. GuruFocus rates SHSE:600381 with a GF Score™ of 70/100 and a GF Value™ of ¥5.28 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Qinghai Spring Medicinal Resources Technology Co's inventories, raw materials & components for the quarter that ended in Jun. 2026 was ¥58.9 Mil.

Qinghai Spring Medicinal Resources Technology Co's quarterly raw materials declined from Dec. 2025 (¥74.5 Mil) to Mar. 2026 (¥0.0 Mil) but then increased from Mar. 2026 (¥0.0 Mil) to Jun. 2026 (¥58.9 Mil).

Qinghai Spring Medicinal Resources Technology Co's annual raw materials declined from Dec. 2023 (¥195.3 Mil) to Dec. 2024 (¥44.7 Mil) but then increased from Dec. 2024 (¥44.7 Mil) to Dec. 2025 (¥74.5 Mil).

Qinghai Spring Medicinal Resources Technology Co Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for Qinghai Spring Medicinal Resources Technology Co's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Qinghai Spring Medicinal Resources Technology Co Inventories, Raw Materials & Components Chart

Qinghai Spring Medicinal Resources Technology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 327.05 239.05 195.28 44.68 74.54

Qinghai Spring Medicinal Resources Technology Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 82.12 0.00 74.54 0.00 58.88
SHSE:600381
70GF Score
Qinghai Spring Medicinal Resources Technology Co Ltd SHSE:600381
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Qinghai Spring Medicinal Resources Technology Co Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of ¥58.9 Mil mean?
Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) has a Inventories, Raw Materials & Components of ¥58.9 Mil as of Jun. 2026. Raw materials are the components a company uses for its main products. View historical data on Qinghai Spring Medicinal Resources Technology Co and its competitors.
Is Qinghai Spring Medicinal Resources Technology Co's Inventories, Raw Materials & Components too high?
Qinghai Spring Medicinal Resources Technology Co's current Inventories, Raw Materials & Components is ¥58.9 Mil. Overall, Qinghai Spring Medicinal Resources Technology Co has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Qinghai Spring Medicinal Resources Technology Co's Inventories, Raw Materials & Components compare to ZTS?
Qinghai Spring Medicinal Resources Technology Co's Inventories, Raw Materials & Components of ¥58.9 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on Qinghai Spring Medicinal Resources Technology Co and its competitors. Qinghai Spring Medicinal Resources Technology Co's current Inventories, Raw Materials & Components is ¥58.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qinghai Spring Medicinal Resources Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥5.28, compared to a current price of ¥4.29 — trading 18.8% below its estimated fair value. The current Inventories, Raw Materials & Components is ¥58.9 Mil. Qinghai Spring Medicinal Resources Technology Co's overall GF Score™ is 70/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For Qinghai Spring Medicinal Resources Technology Co (SHSE:600381), the current Inventories, Raw Materials & Components is ¥58.9 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Qinghai Spring Medicinal Resources Technology Co (SHSE:600381) Overvalued in 2026?

Based on GuruFocus' analysis, Qinghai Spring Medicinal Resources Technology Co stock appears to be undervalued. The current stock price of ¥4.29 is trading 18.8% below its estimated GF Value™ of ¥5.28. GuruFocus considers Qinghai Spring Medicinal Resources Technology Co to be Modestly Undervalued.

Key valuation signals for SHSE:600381:

  • Inventories, Raw Materials & Components: ¥58.9 Mil
  • GF Value™: ¥5.28 vs. price of ¥4.29 (18.8% below fair value)
  • GF Score™: 70/100 with 1 warning sign

No single metric tells the full story. See the SHSE:600381 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Qinghai Spring Medicinal Resources Technology Co Business Description

Address East New Road 1, Xining Economic and Technological Development Zone, Xining, CHN, 810007
Qinghai Spring Medicinal Resources Technology Co Ltd is a China-based company that principally engaged in the integrated development, utilization, production, sales, and consulting services of the natural advantageous resources on the Qinghai-Tibet plateau, as well as the development and utilization of other biological resources. The Company's main products are the cordyceps sinensis series products under the Verygrass brand, which includes cordyceps sinensis pure powder tablet, processed cordyceps sinensis, and raw cordyceps sinensis.
70GF Score

Get the complete analysis for SHSE:600381

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥4.29
Price
¥5.28
GF Value